Trustees of Columbia University in the City of New York’s Jade Biosciences JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-377
Closed -$266K 17
2023
Q1
$266K Hold
377
0.48% 14
2022
Q4
$386K Buy
+377
New +$274K 0.8% 11

Other funds holding JBIO

Trustees of Columbia University in the City of New York's JBIO Position: Q2 2023 in Review

Trustees of Columbia University in the City of New York sold out of Jade Biosciences (JBIO) in Q2 2023, closing a stake of 377 shares — an estimated $266K sold.

Trustees of Columbia University in the City of New York first reported a position in JBIO in Q4 2022 and held it in 2 quarters. The position peaked at $386K in Q4 2022. 59 funds tracked by Wall St. Rank hold JBIO as of Q2 2023.

  • Trustees of Columbia University in the City of New York reported no remaining Jade Biosciences position as of Q2 2023 after selling out during the quarter.
  • Trustees of Columbia University in the City of New York sold 377 Jade Biosciences shares in Q2 2023, an estimated $266K.
  • Trustees of Columbia University in the City of New York first reported a position in Jade Biosciences in Q4 2022 and held it in 2 quarters.
  • Trustees of Columbia University in the City of New York's Jade Biosciences position peaked at $386K in Q4 2022.
  • 59 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2023.

Based on Trustees of Columbia University in the City of New York's 13F filing for Q2 2023, filed 14 Aug 2023.